Johnson & Johnson (JNJ) Tops Q3 EPS by 7c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3
October 15, 2014 7:23 AM EDTBofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while reiterated a Neutral rating following 'solid' Q3 results.
Hopkins said while solid the quarter also highlighted a number of likely EPS headwinds for... More
